文献速递老年慢病共病管理老年综合评估衰弱、肌少症与跌倒

老年心血管疾病患者常见非心血管多病模式与临床结局

Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.
PubMed 文献 · J Am Geriatr Soc · 2023-06-24

基于2015-2016年Medicare数据,对AMI、CHF和AF三个队列进行潜在类别分析,识别出四种非心血管多病模式:minimal、depression-lung、CKD-diabetes和multi-system。多系统类与最高的死亡、心血管住院、非心血管住院和居家时间损失风险相关(HR 2.7-3.9等)。在AMI中CKD-diabetes类与不良结局的关联强于depression-lung类。

要点

  • 三种心血管病队列均识别出四种非心血管多病模式:minimal、depression-lung、CKD-diabetes、multi-system。
  • 多系统类死亡风险HR 2.7-3.9,非心血管住院HR 3.1-7.2,居家时间损失率比2.7-5.4。
  • AMI中CKD-diabetes类与所有不良结局的关联强于depression-lung类。

核心结论

  • 在Medicare CHF、AMI或AF受益人中发现四种非心血管多病模式,与minimal类相比,multi-system、CKD-diabetes和depression-lung类与更差结局相关。

研究设计与样本

  • 使用2015-2016年Medicare数据,取1%随机样本,创建AMI(n=24,808)、CHF(n=57,285)和AF(n=36,277)三个队列。
  • 在每个队列中,基于9种非心血管共病(贫血、癌症、慢性肾病、慢性肺病、痴呆、抑郁、糖尿病、甲状腺功能减退和肌肉骨骼疾病)应用潜在类别分析进行分类。
  • 比较不同非心血管多病类别间1年随访期间的死亡率、心血管和非心血管住院以及居家时间损失。

主要发现

  • 三个CVD队列均出现相似的非心血管多病类别:minimal、depression-lung、CKD-diabetes和multi-system。
  • 跨CVD队列,multi-system类死亡风险最高(HR 2.7-3.9),心血管住院HR 1.6-3.3,非心血管住院HR 3.1-7.2,居家时间损失率比2.7-5.4。
  • 在AMI中,CKD-diabetes类与所有不良结局的关联强于depression-lung类。
  • 在CHF和AF中,depression-lung类与CKD-diabetes类的风险差异因结局而异;depression-lung和multi-system类的非心血管住院率是心血管住院率的两倍。

关键数值与推荐

  • 多系统类死亡风险HR 2.7-3.9(跨CVD队列)。
  • 多系统类心血管住院HR 1.6-3.3,非心血管住院HR 3.1-7.2。
  • 多系统类居家时间损失率比2.7-5.4。
  • 在CHF和AF中,depression-lung和multi-system类的非心血管住院率是心血管住院率的两倍。

临床怎么用

  • 识别这些非心血管多病类别可能有助于发现可能从超出常规心血管照护中获益的特定人群。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Among older adults, non-cardiovascular multimorbidity often coexists with cardiovascular disease (CVD) but their clinical significance is uncertain. We identified common non-cardiovascular comorbidity patterns and their association with clinical outcomes in Medicare fee-for-service beneficiaries with acute myocardial infarction (AMI), congestive heart failure (CHF), or atrial fibrillation (AF). METHODS: Using 2015-2016 Medicare data, we took 1% random sample to create 3 cohorts of beneficiaries diagnosed with AMI (n = 24,808), CHF (n = 57,285), and AF (n = 36,277) prior to 1/1/2016. Within each cohort, we applied latent class analysis to classify beneficiaries based on 9 non-cardiovascular comorbidities (anemia, cancer, chronic kidney disease, chronic lung disease, dementia, depression, diabetes, hypothyroidism, and musculoskeletal disease). Mortality, cardiovascular and non-cardiovascular hospitalizations, and home time lost over a 1-year follow-up period were compared across non-cardiovascular multimorbidity classes. RESULTS: Similar non-cardiovascular multimorbidity classes emerged from the 3 CVD cohorts: (1) minimal, (2) depression-lung, (3) chronic kidney disease (CKD)-diabetes, and (4) multi-system class. Across CVD cohorts, multi-system class had the highest risk of mortality (hazard ratio [HR], 2.7-3.9), cardiovascular hospitalization (HR, 1.6-3.3), non-cardiovascular hospitalization (HR, 3.1-7.2), and home time lost (rate ratio, 2.7-5.4). Among those with AMI, the CKD-diabetes class was more strongly associated with all the adverse outcomes than the depression-lung class. In CHF and AF, differences in risk between the depression-lung and CKD-diabetes classes varied per outcome; and the depression-lung and multi-system classes had double the rates of non-cardiovascular hospitalizations than cardiovascular hospitalizations. CONCLUSION: Four non-cardiovascular multimorbidity patterns were found among Medicare beneficiaries with CHF, AMI, or AF. Compared to the minimal class, the multi-system, CKD-diabetes, and depression-lung classes were associated with worse outcomes. Identification of these classes offers insight into specific segments of the population that may benefit from more than the usual cardiovascular care.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Sison SDM, Lin KJ, Najafzadeh M, et al. Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease. J Am Geriatr Soc. 2023. PMID: 37354026. doi:10.1111/jgs.18479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。